We showed that downregulation of ARHGAP29 expression in the breast cancer cell lines examined (HCC1806, MCF-7-EMT, T-47D-EMT) was associated with significantly reduced invasiveness. This evidence concerns the gene ARHGAP29 and breast cancer.